Oligonucleotide Synthesis Market To Witness Heavy Growth Prospects Via - Key players Evonetix, GenScript, Twist Biosciences, Nuclera Nucleics, Synthomics, Helixworks, Iridia

Global oligonucleotide synthesis market, based on product was segmented into synthesized oligonucleotides, reagents, and equipment. In 2018, the synthesized oligonucleotides segment held a largest market share of 48.3% of the oligonucleotide synthesis market, by product. This segment is also expected to dominate the market in 2027 owing to increasing use of the product in research and diagnostic purposes. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.

Get sample PDF Copy of oligonucleotide synthesis market study @ https://www.theinsightpartners.com/sample/TIPBT00002549/?opr-10144

According to a new market research study titled 'Oligonucleotide Synthesis market - Global Analysis and Forecasts by Product, Application and End User. The global oligonucleotide synthesis market is expected to reach US$ 3,971.7 Mn in 2027 from US$ 1,584.2 Mn in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027. The report highlights the trends prevalent in the global oligonucleotide synthesis market and the factors driving the market along with those that act as deterrents to its growth.

Some of the players operating in oligonucleotide synthesis market are, Molecular Assemblies, Twist Bioscience, Evonetix, Nuclera Nucleics Ltd., Camena Bio, DNA Script, Iridia, Inc., Helixworks, Ansa Biotechnologies, Inc., and Synthomics, Inc., among others. The market players have been establishing partnerships as well as collaborations in the market, which enables them to hold a strong position in the market. For instance, in October, 2018, EVONETIX LTD pioneering an innovative approach to scalable and high-fidelity gene synthesis, and LioniX International, a leading global provider of customised microsystem solutions in scalable production volumes, collaborated to scale up production of prototype microelectromechanical systems (MEMs) for DNA synthesis.The developments performed by the companies are helping the market to grow in the coming years.

Increasing applications of synthesized oligonucleotides, increasing investments for synthetic biology and technological advancements genome editing tools are the key driving factors for the growth of the market in the forecast period. However, the growth of the market is restrained by factors such as renewed regulations for biotechnology and lack of skilled professionals in life science industry.

Globally, the synthetic biology has set benchmark with its innovations and the dynamic results. The industry has attracted various global leaders to invest for synthetic biology. For instance, synthetic DNA manufacturer DNA Script has announced a Series A fundraising of 11 million euros ($13 million) led by Illumina Ventures, with additional investment from Merck Ventures BV, the corporate venture arm of Merck KGaA, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners. Owing to the rising investment for the synthetic biology companies, the need and demand for the synthetic biology for the development of the new techniques may increase the market in the future years.

Table of Content:

INTRODUCTION

1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Global Oligonucleotide Synthesis Market - By Product
1.3.2 Global Oligonucleotide Synthesis Market - By Application
1.3.3 Global Oligonucleotide Synthesis Market - By End User
1.3.4 Global Oligonucleotide synthesis Market - By Geography
2. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 KEY MARKET DRIVERS
4.3.1 Increasing Applications of Synthesized Oligonucleotides
4.3.2 Increasing Investments for Synthetic Biology
4.3.3 Technological Advancements Genome Editing Tools
4.4 KEY MARKET RESTRAINTS
4.4.1 Renewed Regulations for Biotechnology
4.4.2 Lack Of Skilled Professionals In Life Science Industry
4.5 KEY MARKET OPPORTUNITIES
4.5.1 Collaborations -- The Future of Innovation
4.6 FUTURE TRENDS
4.6.1 Advancements in Synthetic Biology
4.7 IMPACT ANALYSIS

Buy Now This Report @ https://www.theinsightpartners.com/buy/TIPBT00002549/?opr-10144

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.